ay . CHEMICAL MARKERS IN EARLY CANCER DETECTION A. M. Duffield and J. Lederberg Department of Genetics Stanford University Medical School Stanford, California 94305 For several years we have been developing the technique of gas chroma- tography-mass spectrometry (GC/MS) under computer management for the identification of the metabolites present in body fluids. Our analytical procedure involves chemical fractionation into solvent extractables (acids, phenols, neutrals); bases (amines, amino acids) and carbohy- drates. Each fraction must be derivatized to increase its volatility © for GC/MS analysis. The point of departure in our applying GC/MS to the identification of metabolites present in physiological fluids was a study of the urinary profiles of normal infants and those afflicted with late metabolic acidosis. Following this investigation, we commenced analyzing body fluids from patients with clinical symptoms suggestive of genetic disease. Concurrent with tnis last objective we commeuced a study directed at the recognition of urinary metabolites from children suffering from various: leukemias. During this research we observed the frequent urinary. excretion (milligrams to one gram per day) of beta-aminoisobutyric acid (BAIB). Out of a total of 20 children 12 were found to excrete BAIB, the concentration of which dropped appreciably as the patient continued drug therapy. We observed that the gas chromatographic peak corresponding to BAIB was often contaminated making its quantitation inaccurate by this method. This observation led us to develop a specific and sensitive method for the measurement of BAIB levels in biological fluids. The procedure relies on the technique of mass fragmentography in which the mass spectrometer is used as a specific ion detector for the gas chromato- graph. The urinary amine fraction is derivatized and the mass spec- trometer directed to sample only two ions known to be characteristic for derivatized BAIB and the internal standard. Quantitation is achieved knowing the relative ionization efficiencies of BAIB and the internal standard. Our attack on the problem of.early cancer detection will involve the screening of urine samples for chemical markers idiosyncratic for cancers of the urinary tract. We also intend to quantitate levels of BAIB and protein amino acids for the same patients and controls. )- eed cct Ant ?